xdrc
Bluelighter
- Joined
- Dec 23, 2022
- Messages
- 559
I think Shulgin never really did the ergoline chemistry in his laboratory. Instead, he white-washed reports from the Nichols laboratory and their chemistry. Reading the Pharmacology Notebooks found on Erowid sure is very insightful (https://www.erowid.org/library/books_online/shulgin_labbooks/). I particularly recommend reading the report on "Eric Holland's" LSD (gee, I wonder who that is) vs. their old stash of Sandoz LSD - p. 456, Pharmacology Notebook D. It is a fun anecdote. But in general, if you take a look at TiHKAL and compare to PiHKAL, it seems like the Shulgins ran out of steam a little bit. Interestingly, Wendy Tucker (daughter of Ann Shulgin) once said that Ann was more of a phenethylamine person, while 'Sasha' was drawn more towards the tryptamines. Of course I have no way to verify that. I've heard from people close to 'Sasha' that his favourite compound was indeed LSD though. Again, not sure if he himself ever said that in an interview or anything. Interestingly, in the interview of Robert Oberlender by Morris (see Oberlender interview YouTube, time: 54:29), Dr. Oberlender claims the precursor for the early lysergamide chemistry work in the Nichols lab was given by Shulgin, who has gotten it from... ...and then he halts the sentence suspiciously.
My question was really just for you to clarify which compound you meant with the training wheels - I assume you mean the N6-allyl compound (i.e. AL-LAD), rather than a (afaik yet to be made) N-allyl lysergic acid amide (different amide substitution on carbonyl dangling of C8). If you indeed mean AL-LAD, can you please confirm this in a full sentence? Btw, regarding changes in nomenclature: I just opened "Die Mutterkornalkaloide" by Hofmann, printed 1964, and sure enough, the numbering has stayed the same of these ergoline compounds.
Talking about amide substitution, I found it interesting that Ballz_Trippington mentioned said suspected LSB was aphroidisiac. I've recently got a small sample of an interesting LSD analogue with slightly altered amide residues (which compound will have to be disclosed once I finish my bioassaying) of which basically the only information I have is that it makes incredibly horny. However, I remain doubtful until tested.
By the way, it's not only the UK and US with a proactive approach. Many western nations have adopted analogue laws by now, unfortunately for the research chemical community NL has joined the ranks...
Yes, I agree that the NBOx class is certainly much more dangerous than the known compounds of the lysergamide class. But I do think your earlier speculation that it has to do with off-target binding is wrong. I'm not a pharmacologist either, but my money is on 5-HT2A activation being a driving factor for the toxicity. Of course my claims are only based on binding data of the unmetabolised compound, so who knows what is truly happening. I'd love to know - maybe it would be possible to invent compounds of similar potency with less toxicity.
My question was really just for you to clarify which compound you meant with the training wheels - I assume you mean the N6-allyl compound (i.e. AL-LAD), rather than a (afaik yet to be made) N-allyl lysergic acid amide (different amide substitution on carbonyl dangling of C8). If you indeed mean AL-LAD, can you please confirm this in a full sentence? Btw, regarding changes in nomenclature: I just opened "Die Mutterkornalkaloide" by Hofmann, printed 1964, and sure enough, the numbering has stayed the same of these ergoline compounds.
Talking about amide substitution, I found it interesting that Ballz_Trippington mentioned said suspected LSB was aphroidisiac. I've recently got a small sample of an interesting LSD analogue with slightly altered amide residues (which compound will have to be disclosed once I finish my bioassaying) of which basically the only information I have is that it makes incredibly horny. However, I remain doubtful until tested.
By the way, it's not only the UK and US with a proactive approach. Many western nations have adopted analogue laws by now, unfortunately for the research chemical community NL has joined the ranks...
My simple concludion is that the vast majority of the lysergamides are reasonably safe )in terms of acute toxicity) even when taken to excessive doses, but some of the NBomb family can be dangerous. It comes as no surprise to be that orally they are far less active as the liver has enzymes to N-debenzylate secondary aminnes so I suggest it's pushed users towards ROAs that avoid first pass metabolism and there lies the danger. By definition there is no such thing as a safe drug but I don't think you can argue with forensic analysis. I'm uncertain that anyone had died due to the toxicity of the lysergamides, but the NBomes appear to pose a danger to people who choose to use them.
Yes, I agree that the NBOx class is certainly much more dangerous than the known compounds of the lysergamide class. But I do think your earlier speculation that it has to do with off-target binding is wrong. I'm not a pharmacologist either, but my money is on 5-HT2A activation being a driving factor for the toxicity. Of course my claims are only based on binding data of the unmetabolised compound, so who knows what is truly happening. I'd love to know - maybe it would be possible to invent compounds of similar potency with less toxicity.
Last edited:
